Effects of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with heart failure - Proposal of a novel mechanism of action

Medicine & Life Sciences

• Sodium-Glucose Transport Proteins 100%
• Heart Failure 51%
• empagliflozin 41%
• Hydrogen 30%
• Sodium 29%
• Sodium-Hydrogen Exchangers 23%
• Osmotic Diuretics 15%
• Therapeutics 11%
• Spironolactone 11%
• Glucose 11%
• Natriuretic Peptides 10%
• Body Fluids 9%
• Cardiomegaly 9%
• Kidney 9%
• Diuretics 8%
• Type 2 Diabetes Mellitus 6%
• Fibrosis 6%
• Myocardial Infarction 6%
• Body Weight 6%
• Stroke 6%
• Heart 5%
• Blood Pressure 5%
• Mortality 4%
• Wounds and Injuries 4%
• Pharmaceutical Preparations 3%